Clinical Trials Directory

Trials / Completed

CompletedNCT01470573

Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex Vivo

Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Autologous Cells of Sclerocorneal Limbus Amplified ex Vivo

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Fundacion Clinic per a la Recerca Biomédica · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Progenitor limbo sclerocorneal cells have properties of proliferation and differentiation to corneal and conjunctival epithelium. This cells can be isolated and ex vivo expanded using cell culture technics that could permit the biological replacement of damaged ocular surface.

Conditions

Interventions

TypeNameDescription
PROCEDUREbiological replacement corneal surfacethe expanded tissue will be applied to patient to replace the damaged ocular surface

Timeline

Start date
2011-11-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-11-11
Last updated
2012-12-10

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01470573. Inclusion in this directory is not an endorsement.

Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of (NCT01470573) · Clinical Trials Directory